Latest Commercialisation News

Proteomics International secures half a million dollars from the Western Australian Government to accelerate commercialisation of PromarkerEndo, a groundbreaking blood test for early endometriosis diagnosis.

Marquee Resources has entered a non-exclusive collaboration with Chinese metallurgical leader Yantai Jinao to advance testwork and commercial pathways for its Mount Clement Antimony Project in Western Australia.

Condor Energy has signed a non-binding MoU with Promigas Perú to jointly explore natural gas supply and distribution opportunities from the Piedra Redonda gas field, aiming to unlock value in northern Peru’s energy market.

First Graphene has completed its initial industrial-scale shipment of graphene-enhanced TPU masterbatch to PT Alasmas, marking a key milestone in commercialising advanced materials for durable work boots in Southeast Asia.

Elixir Energy has independently certified an additional 189 BCFe of 2C contingent gas resources in Queensland’s Taroom Trough, lifting its total certified resources to approximately 2.8 TCFe. This milestone underscores the company’s expanding footprint in a key Australian gas basin with promising commercial potential.

4DMedical has responded to ASX queries over its FY2025 financial report, clarifying assumptions behind intangible asset valuations and addressing the auditor’s qualified opinion.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

Nanosonics Limited has announced a $20 million on-market share buy-back program for FY26, underscoring its robust financial health and confidence in future growth driven by new product innovations.

Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.

Green Critical Minerals has signed a landmark MoU with South Korea’s Komex Carbon Corporation to co-develop and commercialize Very High Density (VHD) carbon products, marking GCM’s first international commercial agreement and a key step toward revenue generation in 2026.

Orthocell has appointed a second Canadian distributor for its nerve repair device Remplir™, achieving full national coverage and setting the stage for initial sales this quarter.

Temas Resources has launched an accelerated 2,500-metre drilling campaign at its La Blache titanium-vanadium project in Quebec, aiming to refine resource estimates and advance proprietary processing technology.